N. Nash

发表

Localization of neuronal and glial glutamate transporters

A. Levey, J. Rothstein, L. Martin, 1994, Neuron.

The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapine

A. Levey, H. Meltzer, U. Hacksell, 2004, Psychopharmacology.

Cloning and transient expression of genes encoding the human α4 and β2 neuronal nicotinic acetylcholine receptor (nAChR) subunits

S. Arneric, J. Sullivan, T. Giordano, 1995 .

Cloning and transient expression of genes encoding the human alpha 4 and beta 2 neuronal nicotinic acetylcholine receptor (nAChR) subunits.

S. Arneric, J. Sullivan, T. Giordano, 1995, Gene.

Discovery of the first nonpeptide agonist of the GPR14/urotensin-II receptor: 3-(4-chlorophenyl)-3-(2- (dimethylamino)ethyl)isochroman-1-one (AC-7954).

U. Hacksell, D. Weiner, M. Brann, 2002, Journal of medicinal chemistry.

Identification and characterization of novel small molecule Protease Activated Receptor 2 ( PAR 2 ) agonists

K. Schmelzer, J. Lameh, N. Nash, 2008 .

Molecular cloning and pharmacology of functionally distinct isoforms of the human histamine H3 receptor

D. Weiner, M. Brann, N. Nash, 2002, Neuropharmacology.

Identification of the Atypical L-Type Ca2+ Channel Blocker Diltiazem and Its Metabolites As Ghrelin Receptor Agonists

M. Brann, N. Nash, E. Currier, 2007, Molecular Pharmacology.

as Ghrelin receptor agonists

M. Brann, N. Nash, E. Currier, 2007 .

Discovery of novel peptide/receptor interactions: identification of PHM-27 as a potent agonist of the human calcitonin receptor.

M. Brann, N. Nash, E. Currier, 2004, Biochemical pharmacology.

Vectors permitting visual monitoring of simple transposition events.

R. Davies, D. Wilkinson, N. Nash, 1989, Gene.

The N Terminus of Bradykinin When Bound to the Human Bradykinin B2 Receptor Is Adjacent to Extracellular Cys20 and Cys277 in the Receptor*

N. Nash, L. M. Leeb-Lundberg, D. Kyle, 1996, The Journal of Biological Chemistry.

Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies.

S. Hersch, A. Levey, C. Heilman, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Discovery of selective nonpeptidergic neuropeptide FF2 receptor agonists.

A. Scully, J. Lameh, N. Nash, 2009, Journal of medicinal chemistry.

Characterization of the Mas‐related gene family: structural and functional conservation of human and rhesus MrgX receptors

M. Brann, N. Nash, E. Burstein, 2006, British journal of pharmacology.

5-hydroxytryptamine2A receptor inverse agonists as antipsychotics.

M A Geyer, M. Geyer, K. Krebs-Thomson, 2001, The Journal of pharmacology and experimental therapeutics.

Presenilin‐1 protein expression in familial and sporadic Alzheimer's disease

A. Levey, C. Heilman, S. Mirra, 1997, Annals of neurology.

Light and Electron Microscopic Localization of Presenilin-1 in Primate Brain

A. Levey, C. Heilman, J. Lah, 1997, The Journal of Neuroscience.

Monitoring Interactions between Receptor Tyrosine Kinases and Their Downstream Effector Proteins in Living Cells Using Bioluminescence Resonance Energy Transfer

M. Brann, F. Piu, N. Nash, 2007, Molecular Pharmacology.

Pharmacology and Signaling Properties of Epidermal Growth Factor Receptor Isoforms Studied by Bioluminescence Resonance Energy Transfer

D. Weiner, M. Brann, F. Piu, 2007, Molecular Pharmacology.

Identification and Characterization of Novel Small-Molecule Protease-Activated Receptor 2 Agonists

K. Schmelzer, J. Lameh, N. Nash, 2008, Journal of Pharmacology and Experimental Therapeutics.

Very early activation of m-calpain in peripheral nerve during Wallerian degeneration

A. Levey, J. Glass, N. Nash, 2002, Journal of the Neurological Sciences.

A novel vector allowing the expression of genes in a wide range of gram-negative bacteria.

R. Davies, N. Nash, M. Kozlowski, 1988, Gene.

Identification of the First Synthetic Steroidogenic Factor 1 Inverse Agonists: Pharmacological Modulation of Steroidogenic Enzymes

F. Piu, N. Nash, E. Currier, 2008, Molecular Pharmacology.

Intrinsic Efficacy of Antipsychotics at Human D2, D3, and D4 Dopamine Receptors: Identification of the Clozapine Metabolite N-Desmethylclozapine as a D2/D3 Partial Agonist

U. Hacksell, E. Pham, D. Weiner, 2005, Journal of Pharmacology and Experimental Therapeutics.

Dopamine D5 receptor immunolocalization in rat and monkey brain

A. Levey, M. Caron, C. Heilman, 2000, Synapse.

Integrative functional assays, chemical genomics and high throughput screening: harnessing signal transduction pathways to a common HTS readout.

D. Weiner, M. Brann, F. Piu, 2006, Current pharmaceutical design.

Identification of novel selective V2 receptor non-peptide agonists.

M. Brann, F. Piu, J. Lameh, 2008, Biochemical pharmacology.

Cloning and Localization of Exon 5‐Containing Isoforms of the NMDAR1 Subunit in Human and Rat Brains

A. Levey, C. Heilman, H. Rees, 1997, Journal of neurochemistry.

Molecular cloning and pharmacology of functionally distinct isoforms of the human histamine H(3) receptor.

D. Weiner, M. Brann, N. Nash, 2002, Neuropharmacology.

Overview of receptor cloning.

N. Nash, 2001, Current protocols in pharmacology.

Chemical genomics: massively parallel technologies for rapid lead identification and target validation

Uli Hacksell, Norman Nash, Ethan S. Burstein, 2004, Cytotechnology.

Functional Screening of Drug Target Genes

A. Levey, D. Weiner, M. Brann, 2004 .

Dopamine D5 receptor immunolocalization in rat and monkey brain

A. Levey, M. Caron, C. Heilman, 2000, Synapse.

Cloning of M‐calpain 80 kD subunit from the axonal degeneration‐resistant WLDs mouse mutant

A. Levey, J. Glass, I. Dry, 1998, Journal of neuroscience research.